![methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate structure](/static/products/7336/73364-78-0.webp)
methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate
TL;DR: methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate (CAS 73364-78-0) is a chemical compound with molecular formula C16H16N4O7 and molecular weight 376.10 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate
Also Known As: methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate, Methyl 7-oxo-3-pentofuranosyl-3,7-dihydropyrido[2,1-i]purine-9-carboxylate
| Molecular Formula | C16H16N4O7 |
|---|---|
| Molecular Weight | 376.10 g/mol |
| LogP | -2.0 |
| Topological Polar Surface Area | 147.0 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Exact Mass | 376.1019 |
| Heavy Atoms | 27 |
| Complexity | 751.0 |
Chemical Identifiers
| CAS Number | 73364-78-0 |
|---|---|
| SMILES | COC(=O)C1=CC(=O)N2C=NC3=C(C2=C1)N=CN3C4C(C(C(O4)CO)O)O |
| InChIKey | KWIHOMDLMLPIHT-UHFFFAOYSA-N |
Product Overview
methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate (CAS 73364-78-0), with molecular formula C16H16N4O7 and molecular weight 376.10 g/mol. IUPAC: methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate.
Chemical Property Profile of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate
Property Insights of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate
The XLogP value of -2.0 indicates that methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate is hydrophilic (water-soluble), making it suitable for aqueous formulations and biological assay applications. The TPSA of 147.0 Ų indicates high polarity, suggesting methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate may have limited membrane permeability but good aqueous solubility. Following Lipinski's Rule of Five, methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate has 3 hydrogen bond donor(s) and 9 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate?
The CAS number of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate is 73364-78-0.
What is the molecular formula of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate?
The molecular formula of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate is C16H16N4O7.
What is the molecular weight of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate?
The molecular weight of methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate is 376.10 g/mol.
Where can I buy methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate?
You can request a quote for methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate?
Yes, KEHONG BIO provides custom synthesis services for methyl 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-oxopyrido[2,1-f]purine-9-carboxylate and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.